MicroPort CardioFlow Medtech Corporation

As of December 31, 2025, MicroPort CardioFlow Medtech Corporation carries a market capitalization of 7.70B, placing it among publicly traded companies globally. Its enterprise value stands at 8.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MicroPort CardioFlow Medtech Corporation's next confirmed earnings release is scheduled for March 30, 2027.

As of December 31, 2025, MicroPort CardioFlow Medtech Corporation has 1.27B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, MicroPort CardioFlow Medtech Corporation maintains a current ratio of 2.53, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on August 31, 2026, MicroPort CardioFlow Medtech Corporation's stock has declined approximately 96.21% over the past 52 weeks. The 50-day moving average sits at 1.19, while the 200-day moving average is 12.19.

As of December 31, 2025, MicroPort CardioFlow Medtech Corporation holds 1.39B in cash and equivalents against 1.81B in total debt, resulting in a net debt position of 1.06B. Total book value stands at 1.99B, with working capital of 1.75B providing operational flexibility.

MicroPort CardioFlow Medtech Corporation's most recent stock split took place on March 10, 2026 with a 5:1 split ratio.